REGENXBIO Inc. (RGNX) Social Stream
REGENXBIO Inc (RGNX) Price Targets From Analysts
Use the tables below to see what analysts covering REGENXBIO Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RGNX's average price target has moved down $11.75 over the prior 20 months.
Over the past 50 weeks, RGNX's average upside potential has been 72.93%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RGNX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, RGNX's average broker recommendation rating improved by 0.12.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- RGNX has a lower variance in analysts' estimates than -167.75% of all US stocks.
- In the context of all US stocks, REGENXBIO Inc's upside potential (average analyst target price relative to current price) is higher than 249.36% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENXBIO Inc's average analyst price target is higher than 229.95% of them.
- In the context of Pharmaceutical Products stocks, REGENXBIO Inc's number of analysts covering the stock is greater than 218.57% of them.
Make investment decisions regarding RGNX using the data that counts. Try POWR Ratings for free.